Clinasia
Services >> CDISC Services >> Legacy Study Conversion
     
  Legacy Study Conversion  
     
 

ClinAsia Labs in the process of conversion of clinical trials data to CDISC format makes data ready for regulatory submission. ClinAsia Labs specializes in the conversion of existing raw clinical data to the CDISC formats to ensure they meet the compliance of the regulatory Authorities. The following are the services provided by ClinAsia Labs.

Services:

  • Bookmarks are included in the creation of SDTM CRF annotation.
  • Study data that needs to be converted into submission data tabulation model
    • Legacy study data
    • Ancillary data
    • Trial Design Model tables
  • Analysis data is converted in Analysis data model
  • Metadata  for both clinical and analysis datasets based on the Case Report Tabulation Data Definition Specification
  • Data Reviewer Guide is prepared for the FDA reviewer
  • All deliverables are made ready in submission ready eCTD folders




 
     
  CDISC Mapping Specification
Document
 
  SDTM, ADaM Domain Datasets
Generation
 
  Applications Development Using
CDISC Standards
 
  Legacy Study Conversion  
  ISS/ISE Studies Standardization  
  Comprehensive Validation of
SDTM & ADaM Datasets
 
  Define XML Document  
  eCTD Development & Validation  
  CDISC Training  
     
 
 
ClinAsia Labs successfully provided services to a fortune 500 pharma company in the area of clinical data management.

-----------------------------------------------
ClinAsia Labs has provided end to end clinical research services in the field of Neurology to a global pharma company.

-----------------------------------------------
ClinAsia Labs has recently completed a study pathology with its expertise in the areas of EDC and Regulatory affairs for a global pharma company.

-----------------------------------------------
ClinAsia Labs successfully provided services to a fortune 500 pharma company in the area of clinical data management.

-----------------------------------------------
ClinAsia Labs has provided end to end clinical research services in the field of Neurology to a global pharma company.

-----------------------------------------------
ClinAsia Labs has recently completed a study pathology with its expertise in the areas of EDC and Regulatory affairs for a global pharma company.

-----------------------------------------------
 
 
 
   
   
   
   
 
     
 Copyright © 2008-2009. All Rights Reserved.  Sitemap | Legal Disclaimer